Penumbra

Update in progress

PEN (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Penumbra, Inc. designs, manufactures, and markets medical devices for neurovascular and peripheral procedures in the United States and internationally. Its portfolio includes mechanical thrombectomy systems, aspiration and catheter platforms, embolization coils and delivery systems, neuro evacuation tools, and related accessories. Products are sold through direct sales and distributors. Founded in 2004, based in Alameda, California.

Company score

Sentiment: 0.37; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.21; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.07; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.12; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.02; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.17; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketNYSE (NYQ)
LocationUnited States
CEOMr. Adam Elsesser J.D.
Founded2004
Employees4,700
Websitewww.penumbrainc.com

Identifiers

ISINUS70975L1070
FIGIBBG001BP92V1
LEI549300RGE06P3ECANU72
CUSIP70975L107
CIK0001321732